High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin

被引:14
作者
Di Giovamberardino, Gianna [1 ]
Ferrannini, Michele [2 ]
Testore, Gian Piero [3 ]
Federici, Giorgio [1 ]
Pastore, Anna [1 ]
机构
[1] Childrens Hosp Bambino Gesu IRCCS, Lab Clin Biochem, I-00165 Rome, Italy
[2] Tor Vergata Univ Hosp, Nephrol & Dialysis Unit, I-00133 Rome, Italy
[3] Tor Vergata Univ Hosp, Infect Dis Unit, I-00133 Rome, Italy
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2009年 / 877卷 / 1-2期
关键词
Tazobactam; Piperacillin; Total; Free; HPLC; Assay; PHARMACOKINETICS; PHARMACODYNAMICS; URINE; SERUM;
D O I
10.1016/j.jchromb.2008.11.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-pressure liquid chromatography (HPLC) method with ultraviolet detection was developed for the measurement of plasma free and total tazobactam and piperacillin. This method is simple and fast, requiring only 11 min for the HPLC run and a sample preparation of about 11 min for total drugs and 10min for free drugs. The procedure for the assay involves the treatment of plasma with acetonitrile for total drugs determination, and the use of a centrifugal filter device to deproteinize plasma for free drugs determination. The HPLC column, a Hypersil-ODS, was equilibrated with an eluent mixture composed of acetonitrile-potassium phosphate (pH 2.6). CVs for repeatability of tazobactam and piperacillin measurements ranged from 4.30 to 6.60; CVs for reproducibility ranged from 5.60 to 9.40. Mean analytical recoveries ranged from 100.4 to 103%. A linear relationship was obtained between peak area and drugs concentration in the range studied (0-62.5 mg/L for tazobactam and 0-500 mg/L for piperacillin). The equation for regression line were y = 19x - 1.4 for tazobactam and y = 1.7x - 0.9 for piperacillin; correlation coefficients were > 0.999. The lower limit of quantitation (LLQ) for standard samples was about 0.12 mg/L for tazobactam and 0.49 mg/L for piperacillin, respectively. The lower limit of detection (LLD)was 0.06 mg/L for tazobactam and 0.24 mg/L for piperacillin. This HPLC assay for tazobactam and piperacillin is sensitive and accurate, and provides a reliable determination of both free and total tazobactam and piperacillin in human plasma, thus allowing the determination of these analytes in patients receiving tazocillin therapy. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:86 / 88
页数:3
相关论文
共 13 条
[1]   Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC [J].
Arzuaga, A ;
Isla, A ;
Gascón, AR ;
Maynar, J ;
Martín, A ;
Solinís, MA ;
Toral, D ;
Pedraz, JL .
BIOMEDICAL CHROMATOGRAPHY, 2005, 19 (08) :570-578
[2]   High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine [J].
Augey, V ;
Grosse, PY ;
Albert, G ;
Audran, M ;
Bressolle, F .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1996, 682 (01) :125-136
[3]   Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing [J].
Burgess, DS ;
Waldrep, T .
CLINICAL THERAPEUTICS, 2002, 24 (07) :1090-1104
[4]   Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis [J].
Dalla Costa, T ;
Nolting, A ;
Kovar, A ;
Derendorf, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) :769-778
[5]   RAPID-DETERMINATION OF SULBACTAM AND TAZOBACTAM IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
GUILLAUME, Y ;
PEYRIN, E ;
GUINCHARD, C .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 665 (02) :363-371
[6]   Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam [J].
Kim, MK ;
Xuan, DW ;
Quintiliani, R ;
Nightingale, CH ;
Nicolau, DP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (02) :259-267
[7]   Simultaneous analysis of piperacillin and tazobactam in rabbits: application to pharmacokinetic study [J].
Li, CH ;
Xuan, DW ;
Ye, M ;
Nightingale, CH ;
Nicolau, DP .
BIOMEDICAL CHROMATOGRAPHY, 2005, 19 (01) :99-106
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF A NEW BETA-LACTAMASE INHIBITOR AND ITS METABOLITE IN COMBINATION THERAPY WITH PIPERACILLIN IN BIOLOGICAL-MATERIALS [J].
MARUNAKA, T ;
MANIWA, M ;
MATSUSHIMA, E ;
MINAMI, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 431 (01) :87-101
[9]   DETERMINATION OF TAZOBACTAM AND PIPERACILLIN IN HUMAN-PLASMA, SERUM, BILE AND URINE BY GRADIENT ELUTION REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
OCAMPO, AP ;
HOYT, KD ;
WADGAONKAR, N ;
CARVER, AH ;
PUGLISI, CV .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 496 (01) :167-179
[10]   Antibacterial dosing in intensive care - Pharmacokinetics, degree of disease and pharmacodynamics of sepsis [J].
Roberts, Jason A. ;
Lipman, Jeffrey .
CLINICAL PHARMACOKINETICS, 2006, 45 (08) :755-773